Home > Boards > US Listed > Medical - Drugs > ISTA Pharmaceuticals Inc. (ISTA)

7:30AM ISTA Pharm announces issuance of U.S. patent

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 436
Posts 25,099
Boards Moderated 5
Alias Born 09/11/06
160x600 placeholder
surf1944   Tuesday, 03/27/12 08:35:35 AM
Re: surf1944 post# 63
Post # of 69 
7:30AM ISTA Pharm announces issuance of U.S. patent for Prolensa (ISTA) 8.38 : Co announced that the United States Patent and Trademark Office has issued Patent No. 8,129,431 with claims covering PROLENSA (bromfenac ophthalmic solution), ISTA's once-daily topical nonsteroidal anti-inflammatory product for the treatment of ocular inflammation and pain following cataract surgery. The patent was issued to ISTA's licensor, Senju Pharmaceuticals Co. Ltd., and was granted a patent term adjustment that extends the patent life originally set to expire January 2024 to September 2025.


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist